# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-003672
Filing Date
2024-03-21
Accepted
2024-03-21 09:05:43
Documents
78
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | nxtc-20231231x10k.htm iXBRL | 10-K | 1857840
2 | EX-10.30 | nxtc-20231231xex10d30.htm | EX-10.30 | 413079
3 | EX-23.1 | nxtc-20231231xex23d1.htm | EX-23.1 | 11451
4 | EX-31.1 | nxtc-20231231xex31d1.htm | EX-31.1 | 14967
5 | EX-31.2 | nxtc-20231231xex31d2.htm | EX-31.2 | 14445
6 | EX-32.1 | nxtc-20231231xex32d1.htm | EX-32.1 | 12241
7 | EX-97 | nxtc-20231231xex97.htm | EX-97 | 19670
8 | GRAPHIC | nxtc-20231231x10k005.jpg | GRAPHIC | 46387
9 | GRAPHIC | nxtc-20231231x10k006.jpg | GRAPHIC | 57114
| Complete submission text file | 0001558370-24-003672.txt |  | 7700494

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | EX-101.SCH | nxtc-20231231.xsd | EX-101.SCH | 41400
11 | EX-101.CAL | nxtc-20231231_cal.xml | EX-101.CAL | 54225
12 | EX-101.DEF | nxtc-20231231_def.xml | EX-101.DEF | 121467
13 | EX-101.LAB | nxtc-20231231_lab.xml | EX-101.LAB | 423488
14 | EX-101.PRE | nxtc-20231231_pre.xml | EX-101.PRE | 290111
82 | EXTRACTED XBRL INSTANCE DOCUMENT | nxtc-20231231x10k_htm.xml | XML | 1061798

Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38905 | Film No.: 24769674
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)